pI: 6.6887 |
Length (AA): 210 |
MW (Da): 23727 |
Paralog Number:
4
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127125)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G59980 | Nucleic acid-binding, OB-fold-like protein |
Arabidopsis thaliana | AT2G40660 | nucleic acid-binding, OB-fold-like protein |
Babesia bovis | BBOV_III010240 | tRNA binding domain containing protein |
Candida albicans | CaO19.10141 | one of two distinct genes similar to S. cerevisiae ARC1 (YGL105W) component of amino acyl-tRNA synthetase complexes |
Candida albicans | CaO19.9960 | one of two distinct genes similar to S. cerevisiae ARC1 (YGL105W) tRNA-binding component of amino acyl-tRNA synthetase complexes |
Candida albicans | CaO19.2610 | one of two distinct genes similar to S. cerevisiae ARC1 (YGL105W) component of amino acyl-tRNA synthetase complexes |
Candida albicans | CaO19.2422 | one of two distinct genes similar to S. cerevisiae ARC1 (YGL105W) tRNA-binding component of amino acyl-tRNA synthetase complexes |
Cryptosporidium hominis | Chro.40444 | similar to tyrosyl-tRNA synthetase |
Cryptosporidium parvum | cgd4_3880 | emap RNA binding domain protein (N terminal low complexity region) |
Dictyostelium discoideum | DDB_G0291926 | endothelial monocyte-activating polypeptide II precursor pro-EMAP II family protein |
Dictyostelium discoideum | DDB_G0275611 | hypothetical protein |
Drosophila melanogaster | Dmel_CG8235 | CG8235 gene product from transcript CG8235-RA |
Escherichia coli | b3074 | putative tRNA binding protein |
Echinococcus granulosus | EgrG_001100200 | aminoacyl tRNA synthase complex interacting |
Echinococcus multilocularis | EmuJ_001100200 | aminoacyl tRNA synthase complex interacting |
Giardia lamblia | GL50803_4606 | Methionyl-tRNA synthetase |
Homo sapiens | ENSG00000164022 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
Leishmania braziliensis | LbrM.16.1160 | tyrosyl or methionyl-tRNA synthetase-like protein |
Leishmania braziliensis | LbrM.22.0420 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_161170.1 | tyrosyl or methionyl-tRNA synthetase-like protein |
Leishmania donovani | LdBPK_220350.1 | Putative tRNA binding domain containing protein, putative |
Leishmania infantum | LinJ.16.1170 | tyrosyl or methionyl-tRNA synthetase-like protein |
Leishmania infantum | LinJ.22.0350 | hypothetical protein, conserved |
Leishmania major | LmjF.22.0470 | hypothetical protein, conserved |
Leishmania major | LmjF.16.1130 | tyrosyl or methionyl-tRNA synthetase-like protein |
Leishmania mexicana | LmxM.16.1130 | tyrosyl or methionyl-tRNA synthetase-like protein |
Leishmania mexicana | LmxM.22.0470 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000028029 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
Neospora caninum | NCLIV_006150 | tRNA binding domain containing protein, related |
Oryza sativa | 4335424 | Os04g0303900 |
Oryza sativa | 4327613 | Os01g0821800 |
Plasmodium berghei | PBANKA_1306200 | tRNA import protein tRIP, putative |
Plasmodium falciparum | PF3D7_1442300 | tRNA import protein tRIP |
Plasmodium knowlesi | PKNH_1240000 | tRNA import protein tRIP, putative |
Plasmodium vivax | PVX_118375 | methionine-tRNA ligase, putative |
Plasmodium yoelii | PY02994 | putative methionyl-tRNA synthetase |
Saccharomyces cerevisiae | YGL105W | Arc1p |
Schistosoma japonicum | Sjp_0303990 | Methionyl-tRNA synthetase, cytoplasmic, putative |
Schistosoma mansoni | Smp_073620 | methionyl-tRNA synthetase |
Schmidtea mediterranea | mk4.007045.03 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 |
Schmidtea mediterranea | mk4.017740.00 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 |
Trypanosoma brucei gambiense | Tbg972.8.5270 | tyrosyl/methionyl-tRNA synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.7.2670 | tyrosyl-tRNA synthetase, putative |
Trypanosoma brucei | Tb927.8.5330 | tyrosyl/methionyl-tRNA synthetase, putative |
Trypanosoma brucei | Tb927.7.2400 | tyrosyl-tRNA synthetase, putative |
Trypanosoma congolense | TcIL3000_8_5170 | tyrosyl/methionyl-tRNA synthetase, putative |
Trypanosoma cruzi | TcCLB.511217.200 | tyrosyl or methionyl-tRNA synthetase, putative |
Trypanosoma cruzi | TcCLB.506573.30 | tyrosyl or methionyl-tRNA synthetase, putative |
Trypanosoma cruzi | TcCLB.509207.50 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508321.50 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_223140 | tRNA binding domain-containing protein |
Theileria parva | TP02_0124 | methionyl-tRNA synthetase, putative |
Trichomonas vaginalis | TVAG_336920 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_043270 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_328570 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_000070 | methionyl-tRNA synthetase, putative |
Trichomonas vaginalis | TVAG_228330 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.5330 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.5330 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.5330 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.8.5330 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.7.2400 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.2400 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.2400 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.7.2400 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3074 | Escherichia coli | non-essential | goodall |
PBANKA_1306200 | Plasmodium berghei | Slow | plasmo |
TGME49_223140 | Toxoplasma gondii | Probably non-essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.